Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pharmacogenomic Drug Interaction: early-phase trial registry
5 of 5 indexed Pharmacogenomic Drug Interaction trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 5 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Pharmacogenomic Drug Interaction: 5 US clinical trials tracked, 5 recruiting.
Pharmacogenomic Drug Interaction is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Florida Atlantic University, running 1 of these trials.
Enrollment posture brief
Registry condition pharmacogenomic-drug-interaction
OPEN 5 | RECR 100% | LATE 1 | EARLY 2 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Pharmacogenomic Drug Interaction lists 5 open slots (100% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Pharmacogenomic Drug Interaction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Pharmacogenomic Drug Interaction is recruiting above its size-band peers.
5 of 5 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Pharmacogenomic Drug Interaction research.
Florida Atlantic University accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Pharmacogenomic Drug Interaction enrolment sits around 700 participants.
Median target enrolment is 700 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
Pharmacogenomic Drug Interaction research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Trial of Precision Medicine in Emergency Departments
University of Florida
NCT06448091
The Geriatric Emergency Department Pharmacologic Harm Prevention Project
Florida Atlantic University
NCT07216846
Oral Contraceptive Pill (OCP) Pharmacogenomics
Yale University
NCT06334315
Pharmacogenetic Panel to Prevent Adverse Drug Reactions in Daily Primary Care Practice:
Mayo Clinic
NCT06322238
Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy
Children's Mercy Hospital Kansas City
NCT06554288
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Pharmacogenomic Drug Interaction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Pharmacogenomic Drug Interaction trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Pharmacogenomic Drug Interaction page
5 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Pharmacogenomic Drug Interaction trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Florida Atlantic University sponsors the most Pharmacogenomic Drug Interaction trials on record, review their full trial history before evaluating a specific study. See Florida Atlantic University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pharmacogenomic Drug Interaction condition card totals 5 registered trials; most-linked intervention Panel-based pharmacogenetic genotyping; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.